18-plex COVID-19 Immune Cell Phenotyping
Human PBMCs
Designed for deep immune profiling in human PBMC samples. Identify and quantify 32 distinct cellular phenotypes, including main immune cell subsets as well as cell exhaustion, activation, and proliferation. This panel was developed for the study of COVID-19 samples, but has broad application in infectious disease, immunology, and immuno-oncology.
Benefits
01
True single-cell quantification | Quantify the expression of every marker in the panel for each individual cell in your sample.
02
Visualize Expression | Our image-based approach allows you to see sub-cellular localization and confirm specificity.
03
Re-interrogation | With Canopy's proprietary ZellSafe™ Chip technology, samples can be stored and re-interrogated for additional markers for up to two years.
04
Customizable | Don't see a marker that is critical for your research? Contact us to learn about designing a custom assay of virtually unlimited markers.
Marker List
| Assay Panel (18-plex Target Markers overall) | ||
|---|---|---|
| CD3 | CD4 | CD8 |
| CD11c | CD14 | CD16 |
| CD19 | CD25 | CD27 |
| CD38 | CD45 | CD45RA |
| CD56 | CD123 | CD279 (PD-1) |
| FOXP3 | HLA-DR | Ki67 |
To customize the panel for your specific application, please contact us.
Details & Data
Each cell is segmented individually and the expression value for each marker in the assay is quantified for every cell. FCS data files are generated, and cell populations are determined using classic flow cytometry-like index sorting workflows.
Additional Resources:
